Drug­mak­er fined by Span­ish reg­u­la­tors $10M for 'ex­ces­sive price' of rare dis­ease drug

A com­pa­ny that has been un­der the mi­cro­scope for drug pric­ing be­fore has found it­self fined by Span­ish reg­u­la­tors.

Lea­di­ant Bio­sciences has been

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA